Long/post-COVID in children and adolescents: symptom onset and recovery after one year based on healthcare records in Germany.

COVID-19 Electronic health records Epidemiology Pediatrics Post-COVID

Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
16 Sep 2024
Historique:
received: 05 04 2024
accepted: 09 09 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: aheadofprint

Résumé

Evidence on the incidence and persistence of post-acute sequelae of COVID-19 (PASC) among children and adolescents is still limited. In this retrospective cohort study, 59,339 children and adolescents with laboratory-confirmed COVID-19 in 2020 and 170,940 matched controls were followed until 2021-09-30 using German routine healthcare data. Incidence rate differences (ΔIR) and ratios (IRR) of 96 potential PASC were estimated using Poisson regression. Analyses were stratified according to age (0-11, 12-17 years), and sex. At the individual level, persistence of diagnoses in patients with onset symptoms was tracked starting from the first quarter post-infection. At 0-3 month follow-up, children and adolescents with a previous SARS-CoV-2 infection showed a 34% increased risk of adverse health outcome, and approximately 6% suffered from PASC in association with COVID-19. The attributable risk was higher among adolescents (≥ 12 years) than among children. For most common symptoms, IRRs largely persisted at 9-12 month follow-up. IRR were highest for rare conditions strongly associated with COVID-19, particularly inflammatory conditions among children 0-11 years, and chronic fatigue and respiratory insufficiency among adolescents. Tracking of diagnoses at the individual level revealed similar rates in the decline of symptoms among COVID-19 and control cohorts, generally leaving less than 10% of the patients with persistent diagnoses after 12 months. Although very few patients presented symptoms for longer than 12 months, excess morbidity among children and, particularly, adolescents with a history of COVID-19 means a relevant burden for pediatric care.

Identifiants

pubmed: 39285063
doi: 10.1007/s15010-024-02394-8
pii: 10.1007/s15010-024-02394-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Bundesministerium für Gesundheit
ID : 2521NIK705
Organisme : Bundesministerium für Gesundheit
ID : 2521NIK705
Organisme : Bundesministerium für Gesundheit
ID : 2521NIK705
Organisme : Bundesministerium für Gesundheit
ID : 2521NIK705
Organisme : Bundesministerium für Gesundheit
ID : 2521NIK705
Organisme : Bundesministerium für Gesundheit
ID : 2521NIK705
Organisme : Bundesministerium für Gesundheit
ID : 2521NIK705
Organisme : Bundesministerium für Gesundheit
ID : 2521NIK705
Organisme : Bundesministerium für Gesundheit
ID : 2521NIK705

Informations de copyright

© 2024. The Author(s).

Références

Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40: e482. https://doi.org/10.1097/INF.0000000000003328 .
doi: 10.1097/INF.0000000000003328 pubmed: 34870392 pmcid: 8575095
Pellegrino R, Chiappini E, Licari A, Galli L, Marseglia GL. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181:3995–4009. https://doi.org/10.1007/s00431-022-04600-x .
doi: 10.1007/s00431-022-04600-x pubmed: 36107254 pmcid: 9476461
Organization WH (2023) A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus, 16 February 2023
National Institute for Health and Care Excellence (NICE) (2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19, NICE guideline [NG188]. 2020. Last updated: 11 November 2021. https://www.nice.org.uk/guidance/ ng188
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601–15. https://doi.org/10.1038/s41591-021-01283-z .
doi: 10.1038/s41591-021-01283-z pubmed: 33753937 pmcid: 8893149
Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Network Open. 2021;4:e2128568.
doi: 10.1001/jamanetworkopen.2021.28568 pubmed: 34643720 pmcid: 8515212
Koczulla A, Ankermann T, Behrends U, Berlit P, Berner R, Böing S, et al. S1-leitlinie long-/Post-COVID. Pneumologie. 2022;76:855–907. https://doi.org/10.1055/a-1946-3230 .
doi: 10.1055/a-1946-3230 pubmed: 36479679
Toepfner N, Brinkmann F, Augustin S, Stojanov S, Behrends U. Long COVID in pediatrics—epidemiology, diagnosis, and management. Eur J Pediatr. 2024. https://doi.org/10.1007/s00431-023-05360-y .
doi: 10.1007/s00431-023-05360-y pubmed: 38279014 pmcid: 11001657
United States, Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) (2024) Long COVID Basics. Centers for Disease Control and Prevention. Last accessed: 12 June 2024. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/
Gentilotti E, Górska A, Tami A, et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. 2023;62:102107. https://doi.org/10.1016/j.eclinm.2023.102107 .
doi: 10.1016/j.eclinm.2023.102107 pubmed: 37654668 pmcid: 10466236
Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf Hanson S, Puhan MA. Long COVID through a public health lens: an umbrella review. Public Health Rev. 2022;43:1604501. https://doi.org/10.3389/phrs.2022.1604501 .
doi: 10.3389/phrs.2022.1604501 pubmed: 35359614 pmcid: 8963488
Stephenson T, Shafran R, Ladhani SN. Long COVID in children and adolescents. Curr Opin Infect Dis. 2022;35:461. https://doi.org/10.1097/QCO.0000000000000854 .
doi: 10.1097/QCO.0000000000000854 pubmed: 36098262 pmcid: 9553244
Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5:708–18. https://doi.org/10.1016/S2352-4642(21)00198-X .
doi: 10.1016/S2352-4642(21)00198-X pubmed: 34358472 pmcid: 8443448
Berg SK, Nielsen SD, Nygaard U, Bundgaard H, Palm P, Rotvig C, Christensen AV. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. lancet Child Adolesc Health. 2022;6:240–8. https://doi.org/10.1016/s2352-4642(22)00004-9 .
doi: 10.1016/s2352-4642(22)00004-9
Stephenson T, Pereira SMP, Shafran R, De Stavola BL, Rojas N, McOwat K, et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022;6:230–9. https://doi.org/10.1016/S2352-4642(22)00022-0 .
doi: 10.1016/S2352-4642(22)00022-0 pubmed: 35143770 pmcid: 8820961
Lopez-Leon S, Wegman-Ostrosky T, Ayuzo del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Scientific Reports. 2022;12:9950.
doi: 10.1038/s41598-022-13495-5 pubmed: 35739136 pmcid: 9226045
Behnood S, Newlands F, O’Mahoney L, Haghighat Ghahfarokhi M, Muhid MZ, Dudley J, et al. Persistent symptoms are associated with long term effects of COVID-19 among children and young people: Results from a systematic review and meta-analysis of controlled studies. PLoS One. 2023;18: e0293600. https://doi.org/10.1371/journal.pone.0293600 .
doi: 10.1371/journal.pone.0293600 pubmed: 38153928 pmcid: 10754445
Franco JVA, Garegnani LI, Oltra GV, Metzendorf M-I, Trivisonno LF, Sgarbossa N, Ducks D, Heldt K, Mumm R, Barnes B, et al. Short and long-term wellbeing of children following SARS-CoV-2 infection: a systematic review. Int J Environ Res Public Health. 2022;19:14392. https://doi.org/10.3390/ijerph192114392 .
doi: 10.3390/ijerph192114392 pubmed: 36361269 pmcid: 9657555
Seylanova N, Aiyegbusi OL, Hughes S, Munblit D. Core outcome measurement set for research and clinical practice in post COVID-19 condition (Long COVID) in children and young people: an international delphi consensus study ‘PC-COS Children.’ Eur Respir J. 2023. https://doi.org/10.1183/13993003.01761-2023 .
doi: 10.1183/13993003.01761-2023
Albanji MH, Baghafar AA, Alghanmi YA, Shaaban MM, Alkashlan EA, Sende HH, et al. Clinical presentation and management of multisystem inflammatory syndrome in children with COVID-19: a systematic review. Cureus. 2023. https://doi.org/10.7759/cureus.46918 .
doi: 10.7759/cureus.46918 pubmed: 37954764 pmcid: 10639140
Rotulo GA, Palma P. Understanding COVID-19 in children: immune determinants and post-infection conditions. Pediatric Res. 2023. https://doi.org/10.1038/s41390-023-02549-7 .
doi: 10.1038/s41390-023-02549-7
Stephenson T, Pinto Pereira SM, Nugawela MD, McOwat K, Simmons R, Chalder T, et al. Long COVID—six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: a national matched cohort study (the clock) study. PLoS One. 2023;18: e0277704. https://doi.org/10.1371/journal.pone.0277704 .
doi: 10.1371/journal.pone.0277704 pubmed: 36877677 pmcid: 9987792
Pereira SMP, Shafran R, Nugawela MD, Panagi L, Hargreaves D, Ladhani SN, et al. Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months. Lancet Reg Health-Europe. 2023. https://doi.org/10.1016/j.lanepe.2022.100554 .
doi: 10.1016/j.lanepe.2022.100554
Magnusson K, Skyrud KD, Suren P, Greve-Isdahl M, Størdal K, Kristoffersen DT, Telle K. Healthcare use in 700 000 children and adolescents for six months after covid-19: before and after register based cohort study. BMJ. 2022. https://doi.org/10.1136/bmj-2021-066809 .
doi: 10.1136/bmj-2021-066809 pubmed: 35264329
Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226:1593–607. https://doi.org/10.1093/infdis/jiac136 .
doi: 10.1093/infdis/jiac136 pubmed: 35429399
Roessler M, Tesch F, Batram M, Jacob J, Loser F, Weidinger O, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19: e1004122. https://doi.org/10.1371/journal.pmed.1004122 .
doi: 10.1371/journal.pmed.1004122 pubmed: 36355754 pmcid: 9648706
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12: e1001885. https://doi.org/10.1371/journal.pmed.1001885 .
doi: 10.1371/journal.pmed.1001885 pubmed: 26440803 pmcid: 4595218
Tesch F, Ehm F, Vivirito A, Wende D, Batram M, Loser F, et al. Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study. Clin Rheumatol. 2023. https://doi.org/10.1007/s10067-023-06670-0 .
doi: 10.1007/s10067-023-06670-0 pubmed: 37405528 pmcid: 10497701
Syed U, Subramanian A, Wraith DC, Lord JM, McGee K, Ghokale K, et al. Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care. BMC Med. 2023;21:363. https://doi.org/10.1186/s12916-023-03049-5 .
doi: 10.1186/s12916-023-03049-5 pubmed: 37735654 pmcid: 10512476
Morrow AK, Malone LA, Kokorelis C, Petracek LS, Eastin EF, Lobner KL, et al. Long-term COVID 19 sequelae in adolescents: the overlap with orthostatic intolerance and ME/CFS. Curr Pediatrics Reports. 2022;10:31–44. https://doi.org/10.1007/s40124-022-00261-4 .
doi: 10.1007/s40124-022-00261-4
Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children—a nationwide cohort study. Eur J Pediatr. 2022;181:1597–607. https://doi.org/10.1007/s00431-021-04345-z .
doi: 10.1007/s00431-021-04345-z pubmed: 35000003 pmcid: 8742700
Bilu Y, Flaks-Manov N, Goldshtein I, Bivas-Benita M, Akiva P, Bodenheimer G, Greenfeld S. Youth mental health outcomes up to two years after SARS-CoV-2 infection long-COVID or long-pandemic syndrome: a retrospective cohort study. J Adolesc Health. 2023;73:701–6. https://doi.org/10.1016/j.jadohealth.2023.05.022 .
doi: 10.1016/j.jadohealth.2023.05.022 pubmed: 37389526

Auteurs

Franz Ehm (F)

Center for Evidence-Based Healthcare (ZEGV), University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany. franz.ehm@ukdd.de.

Falko Tesch (F)

Center for Evidence-Based Healthcare (ZEGV), University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany.

Simone Menzer (S)

IKK Classic, Tannenstraße 4 B, 01099, Dresden, Germany.

Friedrich Loser (F)

Techniker Krankenkasse, Bramfelder Straße 140, 22305, Hamburg, Germany.

Lars Bechmann (L)

IKK Classic, Tannenstraße 4 B, 01099, Dresden, Germany.

Annika Vivirito (A)

InGef - Institute for Applied Health Research Berlin GmbH, Otto-Ostrowski-Straße 5, 10249, Berlin, Germany.

Danny Wende (D)

BARMER Institut für Gesundheitssystemforschung (Bifg), Axel-Springer-Straße 44, 10969, Berlin, Germany.

Manuel Batram (M)

Vandage GmbH, Detmolder Str. 30, 33604, Bielefeld, Germany.

Tilo Buschmann (T)

AOK PLUS, Sternplatz 7, 01067, Dresden, Germany.

Marion Ludwig (M)

InGef - Institute for Applied Health Research Berlin GmbH, Otto-Ostrowski-Straße 5, 10249, Berlin, Germany.

Martin Roessler (M)

BARMER Institut für Gesundheitssystemforschung (Bifg), Axel-Springer-Straße 44, 10969, Berlin, Germany.

Martin Seifert (M)

Center for Evidence-Based Healthcare (ZEGV), University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany.

Giselle Sarganas Margolis (G)

Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.

Lukas Reitzle (L)

Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.

Christina Koenig (C)

Techniker Krankenkasse, Bramfelder Straße 140, 22305, Hamburg, Germany.

Claudia Schulte (C)

BARMER Institut für Gesundheitssystemforschung (Bifg), Axel-Springer-Straße 44, 10969, Berlin, Germany.

Pedro Ballesteros (P)

BARMER Institut für Gesundheitssystemforschung (Bifg), Axel-Springer-Straße 44, 10969, Berlin, Germany.

Stefan Bassler (S)

AOK PLUS, Sternplatz 7, 01067, Dresden, Germany.

Thomas Bitterer (T)

IKK Classic, Tannenstraße 4 B, 01099, Dresden, Germany.

Cordula Riederer (C)

DAK-Gesundheit, Nagelsweg 27 - 31, 20097, Hamburg, Germany.

Reinhard Berner (R)

Department of Pediatrics, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany.

Christa Scheidt-Nave (C)

Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.

Jochen Schmitt (J)

Center for Evidence-Based Healthcare (ZEGV), University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany.

Nicole Toepfner (N)

Department of Pediatrics, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany.

Classifications MeSH